November 02, 2023 / 11:48 IST
Reported Consolidated quarterly numbers for Astec Lifesciences are:Net Sales at Rs 110.79 crore in September 2023 down 44.54% from Rs. 199.75 crore in September 2022.
Story continues below Advertisement
Quarterly Net Loss at Rs. 13.43 crore in September 2023 down 173.34% from Rs. 18.31 crore in September 2022.
EBITDA stands negative at Rs. 2.44 crore in September 2023 down 106.55% from Rs. 37.27 crore in September 2022.
Astec Life shares closed at 1,225.80 on November 01, 2023 (NSE) and has given -9.31% returns over the last 6 months and -42.42% over the last 12 months.
Astec Lifesciences | Consolidated Quarterly Results | in Rs. Cr. |
|
| Sep'23 | Jun'23 | Sep'22 | Net Sales/Income from operations | 110.79 | 142.85 | 199.75 | Other Operating Income | -- | -- | -- | Total Income From Operations | 110.79 | 142.85 | 199.75 | EXPENDITURE | Consumption of Raw Materials | 72.38 | 120.77 | 134.68 | Purchase of Traded Goods | -- | -- | -- | Increase/Decrease in Stocks | 3.64 | -18.16 | -11.89 | Power & Fuel | -- | -- | -- | Employees Cost | 17.25 | 15.38 | 15.03 | Depreciation | 9.16 | 9.39 | 8.17 | Excise Duty | -- | -- | -- | Admin. And Selling Expenses | -- | -- | -- | R & D Expenses | -- | -- | -- | Provisions And Contingencies | -- | -- | -- | Exp. Capitalised | -- | -- | -- | Other Expenses | 20.94 | 21.73 | 28.64 | P/L Before Other Inc., Int., Excpt. Items & Tax | -12.58 | -6.25 | 25.11 | Other Income | 0.98 | 1.71 | 3.99 | P/L Before Int., Excpt. Items & Tax | -11.60 | -4.54 | 29.10 | Interest | 5.99 | 6.46 | 4.51 | P/L Before Exceptional Items & Tax | -17.60 | -11.01 | 24.58 | Exceptional Items | -- | -- | -- | P/L Before Tax | -17.60 | -11.01 | 24.58 | Tax | -4.18 | -2.82 | 6.27 | P/L After Tax from Ordinary Activities | -13.42 | -8.19 | 18.31 | Prior Year Adjustments | -- | -- | -- | Extra Ordinary Items | -- | -- | -- | Net Profit/(Loss) For the Period | -13.42 | -8.19 | 18.31 | Minority Interest | -0.01 | -0.01 | -0.01 | Share Of P/L Of Associates | -- | -- | -- | Net P/L After M.I & Associates | -13.43 | -8.19 | 18.31 | Equity Share Capital | 19.61 | 19.61 | 19.60 | Reserves Excluding Revaluation Reserves | -- | -- | -- | Equity Dividend Rate (%) | -- | -- | -- | EPS Before Extra Ordinary | Basic EPS | -6.85 | -4.18 | 9.34 | Diluted EPS | -6.85 | -4.18 | 9.34 | EPS After Extra Ordinary | Basic EPS | -6.85 | -4.18 | 9.34 | Diluted EPS | -6.85 | -4.18 | 9.34 | Public Share Holding | No Of Shares (Crores) | -- | -- | -- | Share Holding (%) | -- | -- | -- | Promoters and Promoter Group Shareholding | a) Pledged/Encumbered | - Number of shares (Crores) | -- | -- | -- | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | b) Non-encumbered | - Number of shares (Crores) | -- | -- | -- | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!